• Health & Medicine

Tackling side effects in head and neck cancer treatment - the end of the road for hyperbaric oxygen?

Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work? Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work?

2 May 2019

• Health & Medicine

Breast cancer relapse test can predict treatment benefits, study suggests

Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests. Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests.

30 April 2019

• Science & Technology

Pancreatic cancers ‘talk’ to neighbouring cells in mice, pointing to potential new drug targets

Scientists have found a new way in which cells that surround pancreatic cancers in mice can help the tumours grow. Scientists have found a new way in which cells that surround pancreatic cancers in mice can help the tumours grow.

23 April 2019

• Science & Technology

Gene editing uncovers potential drug targets for aggressive brain tumours

Potential new drug targets for an aggressive type of brain tumour have been uncovered in the lab, thanks to a ‘reverse engineering’ approach using DNA editing. Potential new drug targets for an aggressive type of brain tumour have been uncovered in the lab, thanks to a ‘reverse engineering’ approach using DNA editing.

18 April 2019

• Health & Medicine

Even moderate red and processed meat eaters at risk of bowel cancer

People who eat red and processed meat within department of health guidelines are still at increased risk of bowel cancer, a Cancer Research UK study* has found. People who eat red and processed meat within department of health guidelines are still at increased risk of bowel cancer, a Cancer Research UK study* has found.

17 April 2019

• Health & Medicine

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer. Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

17 April 2019

• Health & Medicine

Two targeted lung cancer drugs get initial ‘no’ for NHS in England

Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England. Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.

12 April 2019

• Health & Medicine

Breast cancer drug combo gets initial ‘no’ for NHS in England

Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use. Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use.

10 April 2019

• Health & Medicine

Immune-stimulating injection turns tumours into ‘cancer vaccine factories’ in mice

Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice. Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice.

8 April 2019

• Health & Medicine

Prostate cancer hormone therapy rejected on NHS in England

A prostate cancer drug won’t be offered on the NHS any earlier in the treatment plans of patients living with the disease in England. A prostate cancer drug won’t be offered on the NHS any earlier in the treatment plans of patients living with the disease in England.

5 April 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Health & Medicine

Advanced breast cancer drug combo approved for NHS in England

A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England. A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.

3 April 2019